Sivik Global Healthcare LLC

Name: Sivik Global Healthcare LLC 13F holdings, Q3 2025
Creator: Sivik Global Healthcare LLC
Published: 2025-10-23

Q2 2026Q1 2026Q4 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 23, 2025), Sivik Global Healthcare LLC reported 35 stock positions worth $190.5 million. Its top holding was SS SPDR S&P Biotech ETF (XBI) at 13.2% of the portfolio, followed by Eli Lilly (LLY, 4.0%) and HCA Healthcare (HCA, 3.8%). Compared with Q2 2025, it opened 9 new positions, sold out of 12, added to 3 and reduced 20. The biggest buy was a new position in Thermo Fisher Scientific (TMO) and the biggest sale an exit from Novo-Nordisk A/S-Spons ADR (NVO).

Most Recent 13F: Q2 2026
Location: GREENWICH, CT
CIK: 0001596452
Portfolio Value: $190.5M (Q3 2025)
SEC Filing: 0001596452-25-000011 ↗ filed Oct 23, 2025

Holdings Value

Holdings 35 stocks · $190.5M


XBI SS SPDR S&P Biotech ETF	13.15%	250,000	$25.1M	No change
LLY Eli Lilly & Co.	4.01%	10,000	$7.6M	Reduce -9.1%
HCA HCA Healthcare Inc.	3.80%	17,000	$7.2M	Reduce -32.0%
THC Tenet Healthcare Corp.	3.73%	35,000	$7.1M	Reduce -58.8%
DHR Danaher Corp.	3.64%	35,000	$6.9M	Reduce -12.5%
BSX Boston Scientific Corp.	3.59%	70,000	$6.8M	Reduce -12.5%
TMO Thermo Fisher Scientific Inc.	3.56%	14,000	$6.8M	New
HUM Humana Inc.	3.41%	25,000	$6.5M	Reduce -7.4%
COR Cencora Inc.	3.28%	20,000	$6.3M	Reduce -20.0%
CAH Cardinal Health Inc.	3.09%	37,500	$5.9M	Reduce -16.7%
ISRG Intuitive Surgical Inc.	3.05%	13,000	$5.8M	No change
SNN Smith & Nephew PLC -Spon ADR	3.05%	160,000	$5.8M	Add +14.3%
UHS Universal Health Services-B	3.00%	28,000	$5.7M	Reduce -46.7%
MDT Medtronic PLC	3.00%	60,000	$5.7M	Reduce -25.0%
VRTX Vertex Pharmaceuticals Inc.	2.88%	14,000	$5.5M	New
MCK McKesson Corp.	2.84%	7,000	$5.4M	Reduce -46.1%
ABT Abbott Laboratories	2.64%	37,500	$5.0M	Reduce -4.3%
SYK Stryker Corp.	2.52%	13,000	$4.8M	Reduce -31.6%
SGRY Surgery Partners Inc.	2.50%	220,000	$4.8M	Add +76.0%
JNJ Johnson & Johnson	2.43%	25,000	$4.6M	New
ABBV Abbvie Inc.	2.43%	20,000	$4.6M	New
EHC Encompass Health Corp.	2.33%	35,000	$4.4M	Add +40.0%
A Agilent Technologies Inc.	2.22%	33,000	$4.2M	Reduce -26.7%
UNH Unitedhealth Group Inc.	2.18%	12,000	$4.1M	Reduce -20.0%
CI The Cigna Group	2.12%	14,000	$4.0M	Reduce -15.2%
ZBH Zimmer Biomet Holdings Inc.	2.07%	40,000	$3.9M	New
WST West Pharmaceutical Services	2.07%	15,000	$3.9M	No change
DGX Quest Diagnostics Inc.	2.00%	20,000	$3.8M	Reduce -20.0%
RGEN Repligen Corp.	1.93%	27,500	$3.7M	Reduce -8.3%
BIO Bio-Rad Laboratories-A	1.62%	11,000	$3.1M	Reduce -38.9%
LH Labcorp Holdings Inc.	1.51%	10,000	$2.9M	New
SEM Select Medical Holdings Corp.	1.18%	175,000	$2.2M	Reduce -41.7%
STVN Stevanato Group SPA	1.15%	85,000	$2.2M	New
BRKR Bruker Corp.	1.02%	60,000	$1.9M	New
GEHC GE Healthcare Technology	0.99%	25,000	$1.9M	New

Options reported separately and not counted above: PUT - SPY 100 @ 645 EXP 10/31/2025 puts ($20.0M), PUT - SPY 100 @ 635 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 660 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 655 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 660 EXP 11/21/2025 puts ($16.7M), PUT - SPY 100 @ 658 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 659 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 639 EXP 10/31/2025 puts ($16.7M), PUT - SPY 100 @ 659 EXP 11/21/2025 puts ($16.7M).

Portfolio Sells Q2 2025 → Q3 2025


NVO Novo-Nordisk A/S-Spons ADR	Sold out	0.00%	−3.09
THC Tenet Healthcare Corp.	Reduce -58.8%	3.73%	−2.96
WAT Waters Corp.	Sold out	0.00%	−2.81
GILD Gilead Sciences Inc.	Sold out	0.00%	−2.48
RVTY Revvity Inc.	Sold out	0.00%	−1.95
MCK McKesson Corp.	Reduce -46.1%	2.84%	−1.42
AVTR Avantor Inc.	Sold out	0.00%	−1.35
ALGN Align Technology Inc.	Sold out	0.00%	−1.27
UHS Universal Health Services-B	Reduce -46.7%	3.00%	−1.25
BAX Baxter International Inc.	Sold out	0.00%	−1.02
COO The Cooper Cos Inc.	Sold out	0.00%	−0.95
ALNY Alnylam Pharmaceuticals Inc.	Sold out	0.00%	−0.95
SEM Select Medical Holdings Corp.	Reduce -41.7%	1.18%	−0.86
SYK Stryker Corp.	Reduce -31.6%	2.52%	−0.84
MDGL Madrigal Pharmaceuticals Inc.	Sold out	0.00%	−0.68
ARGX Argenx SE - ADR	Sold out	0.00%	−0.62
INSP Inspire Medical Systems Inc.	Sold out	0.00%	−0.58
HCA HCA Healthcare Inc.	Reduce -32.0%	3.80%	−0.48
BIO Bio-Rad Laboratories-A	Reduce -38.9%	1.62%	−0.32
CI The Cigna Group	Reduce -15.2%	2.12%	−0.32
CAH Cardinal Health Inc.	Reduce -16.7%	3.09%	−0.29
BSX Boston Scientific Corp.	Reduce -12.5%	3.59%	−0.26
A Agilent Technologies Inc.	Reduce -26.7%	2.22%	−0.15
MDT Medtronic PLC	Reduce -25.0%	3.00%	−0.12
COR Cencora Inc.	Reduce -20.0%	3.28%	−0.07
DGX Quest Diagnostics Inc.	Reduce -20.0%	2.00%	−0.01
UNH Unitedhealth Group Inc.	Reduce -20.0%	2.18%	+0.08
DHR Danaher Corp.	Reduce -12.5%	3.64%	+0.11
LLY Eli Lilly & Co.	Reduce -9.1%	4.01%	+0.17
ABT Abbott Laboratories	Reduce -4.3%	2.64%	+0.25
RGEN Repligen Corp.	Reduce -8.3%	1.93%	+0.26
HUM Humana Inc.	Reduce -7.4%	3.41%	+0.46

Portfolio Buys Q2 2025 → Q3 2025


TMO Thermo Fisher Scientific Inc.	New	3.56%	+3.56
VRTX Vertex Pharmaceuticals Inc.	New	2.88%	+2.88
JNJ Johnson & Johnson	New	2.43%	+2.43
ABBV Abbvie Inc.	New	2.43%	+2.43
ZBH Zimmer Biomet Holdings Inc.	New	2.07%	+2.07
LH Labcorp Holdings Inc.	New	1.51%	+1.51
SGRY Surgery Partners Inc.	Add +76.0%	2.50%	+1.26
STVN Stevanato Group SPA	New	1.15%	+1.15
SNN Smith & Nephew PLC -Spon ADR	Add +14.3%	3.05%	+1.13
BRKR Bruker Corp.	New	1.02%	+1.02
GEHC GE Healthcare Technology	New	0.99%	+0.99
EHC Encompass Health Corp.	Add +40.0%	2.33%	+0.96

Options Activity Q2 2025 → Q3 2025


PUT - SPY 100 @ 599 EXP 07/18/2025	put	Sold out	400	$24.0Mbefore exit
PUT - SPY 100 @ 596 EXP 07/18/2025	put	Sold out	400	$23.8Mbefore exit
PUT - SPY 100 @ 645 EXP 10/31/2025	put	New	300	$20.0M
PUT - SPY 100 @ 602 EXP 07/31/2025	put	Sold out	300	$18.1Mbefore exit
PUT - SPY 100 @ 597 EXP 07/18/2025	put	Sold out	300	$17.9Mbefore exit
PUT - SPY 100 @ 635 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 660 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 655 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 660 EXP 11/21/2025	put	New	250	$16.7M
PUT - SPY 100 @ 658 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 659 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 639 EXP 10/31/2025	put	New	250	$16.7M
PUT - SPY 100 @ 659 EXP 11/21/2025	put	New	250	$16.7M
PUT - SPY 100 @ 610 EXP 08/15/2025	put	Sold out	250	$15.3Mbefore exit
PUT - SPY 100 @ 607 EXP 07/31/2025	put	Sold out	250	$15.2Mbefore exit
PUT - SPY 100 @ 600 EXP 08/15/2025	put	Sold out	250	$15.0Mbefore exit
PUT - SPY 100 @ 593 EXP 07/31/2025	put	Sold out	250	$14.8Mbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	34	$131.7M	XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q1 2026	34	$131.7M	XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q4 2025	41	$204.8M	XBI, LLY, THC, MCK, HCA
Q3 2025	35	$190.5M	XBI, LLY, HCA, THC, DHR
Q2 2025	38	$223.6M	XBI, THC, HCA, MCK, UHS
Q1 2025	29	$182.9M	XBI, BSX, THC, HCA, LLY
Q4 2024	36	$180.8M	XBI, LLY, BSX, MCK, SYK
Q3 2024	33	$234.6M	XBI, LLY, THC, NVO, UHS
Q2 2024	37	$223.9M	LLY, NVO, MCK, THC, BSX
Q1 2024	46	$275.1M	XBI, LLY, NVO, BSX, TMO